BioMarin Pharmaceutical Inc. (BMRN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioMarin Pharmaceutical I...

    NASDAQ: BMRN · Real-Time Price · USD
    57.77
    1.02 (1.80%)
    At close: Sep 05, 2025, 3:59 PM
    57.77
    0.00%
    After-hours: Sep 05, 2025, 07:54 PM EDT

    BioMarin Pharmaceutical Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 942.84M 755.13M 724.53M 587.28M
    Short-Term Investments
    		 194.86M 318.68M 567.01M 426.6M
    Long-Term Investments
    		 521.24M 611.13M 333.83M 507.79M
    Other Long-Term Assets
    		 251.39M 171.54M 176.24M 152.12M
    Receivables
    		 660.53M 633.7M 461.32M 373.4M
    Inventory
    		 1.23B 1.11B 894.08M 776.67M
    Other Current Assets
    		 201.53M 141.39M 104.52M 110.44M
    Total Current Assets
    		 3.23B 2.96B 2.75B 2.27B
    Property-Plant & Equipment
    		 1.04B 1.07B 1.07B 1.04B
    Goodwill & Intangibles
    		 451.48M 490.9M 534.77M 584.85M
    Total Long-Term Assets
    		 3.76B 3.89B 3.62B 3.73B
    Total Assets
    		 6.99B 6.84B 6.38B 6B
    Account Payables
    		 235.4M 315.51M 231.24M 199.68M
    Deferred Revenue
    		 1.37M 4.62M 711K 6.96M
    Short-Term Debt
    		 n/a 493.88M n/a n/a
    Other Current Liabilities
    		 215.57M 234.92M 236.1M 258.94M
    Total Current Liabilities
    		 606.99M 1.18B 588.88M 546.5M
    Long-Term Debt
    		 595.14M 593.1M 1.08B 1.08B
    Other Long-Term Liabilities
    		 128.82M 119.94M 100.02M 113.53M
    Total Long-Term Liabilities
    		 723.96M 713.03M 1.18B 1.19B
    Total Liabilities
    		 1.33B 1.89B 1.77B 1.74B
    Total Debt
    		 602.71M 1.1B 1.09B 1.09B
    Common Stock
    		 191K 189K 186K 184K
    Retained Earnings
    		 -194.69M -621.55M -789.2M -930.76M
    Comprehensive Income
    		 61.65M -28.79M -3.87M 14.43M
    Shareholders Equity
    		 5.66B 4.95B 4.6B 4.27B
    Total Investments
    		 716.1M 929.82M 900.84M 934.39M

    Add to Watchlist